重大事件
即時報告
8-K
2026-06-24
Scilex Holding股東年會通過所有議案 股權激勵計劃擴容130萬股
AI 繁中摘要
📄 **8-K 申報:Scilex Holding Company 2026 年股東年會投票結果**
Scilex Holding Company(納斯達克代碼:SCLX / SCLXW)於 2026 年 6 月 24 日舉行年度股東大會,並提交 8-K 表格彙報投票結果。截至記錄日 2026 年 4 月 28 日,已發行及流通的 Series A 優先股為 29,057,097 股(全數出席),普通股為 8,491,267 股(約 63.5% 出席)。因優先股轉換價調整,優先股股東按轉換基準合共擁有 848,106 票。
會議審議三項提案,結果如下:
**提案 1:選舉 Class I 董事**
- 唯一候選人 Dorman Followwill 獲 3,945,473 票贊成、410,969 票反對、1,880,745 票券商棄權,順利當選,任期至 2029 年股東年會。
**提案 2:批准 BPM LLP 為 2026 年度核數師**
- 贊成 5,956,622 票、反對 207,998 票、棄權 72,567 票,提案獲得通過。
**提案 3:修訂 2022 年股權激勵計劃**
- 增加授權發行股份 1,300,000 股,使總授權數升至 2,765,789 股(包括 ISO 限制);投票結果:贊成 3,337,435 票、反對 1,009,991 票、棄權 9,016 票、券商棄權 1,880,745 票,提案通過。
📊 **投資者影響**
是次股東會順利通過所有議案,反映主要股東對管理層及核數師的支持。值得注意的是,股權激勵計劃的擴容(新增 130 萬股)可能帶來潛在攤薄效應,但一般被視為吸引及留住人才的正面措施。公司未有在簡報中提供財務展望,投資者後續宜關注 10-Q 或 10-K 的業績披露。
展開英文正文
8-K false00018201900001820190sclx:WarrantsToPurchaseOneShareOfCommonStockEachAtAnExercisePriceOf40250PerShareMember2026-06-242026-06-2400018201902026-06-242026-06-240001820190sclx:CommonStockParValue00001PerShare2Member2026-06-242026-06-24 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________ FORM 8-K _______________________ CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 24, 2026 _______________________ SCILEX HOLDING COMPANY (Exact name of registrant as specified in its charter) _______________________ Delaware (State or other jurisdiction of incorporation) 001-39852 (Commission File Number) 92-1062542 (IRS Employer Identification No.) 960 San Antonio Road, Palo Alto, California, 94303 (Address of principal executive offices, including zip code) (650) 516-4310 Registrant’s telephone number, including area code N/A (Former Name or Former Address, if Changed Since Last Report) _______________________ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Exchange Act: (Title of each class) (Trading Symbol) (Name of exchange on which registered) Common Stock, par value $0.0001 per share SCLX The Nasdaq Stock Market LLC Warrants to purchase one share of common stock, each at an exercise price of $402.50 SCLXW The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☒ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒ Item 5.07. Submission of Matters to a Vote of Security Holders. On June 24, 2026, Scilex Holding Company (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Meeting”). At the Meeting, a total of (i) 29,057,097 shares of the Company’s Series A preferred stock, $0.0001 par value per share (the “Series A Preferred Stock”), or 100% of the 29,057,097 shares of Series A Preferred Stock, issued and outstanding, and (ii) 5,389,081 shares of the Company’s common stock, $0.0001 par value per share (the “Common Stock”), or approximately 63.5% of the 8,491,267 shares of Common Stock, issued and outstanding, both as of the close of business on April 28, 2026, the record date for the Meeting, were represented virtually or by proxy. The holder of Series A Preferred Stock was entitled to vote, together with the holders of Common Stock and not separately as a class, on an as converted to Common Stock basis for an aggregate of 848,106 votes as a result of the adjustments to the deemed conversion price of such preferred stock in accordance with the Certificate of Designations of Series A Preferred Stock, filed with the Delaware Secretary of State on November 10, 2022. At the Meeting, the Company’s stockholders considered three proposals, each of which is described in more detail in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on April 30, 2026. Set forth below is a brief description of each proposal voted upon at the Meeting and the voting results with respect to each proposal. Proposal No. 1: To elect the following nominee as a Class I director to serve until the Company’s 2029 Annual Meeting of Stockholders. Nominee For Withhold Broker Non-Votes Dorman Followwill 3,945,473 410,969 1,880,745 Proposal No. 2: To ratify the appointment of BPM LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year ending December 31, 2026. For Against Abstentions 5,956,622 207,998 72,567 Proposal No. 3: To approve the amendment to the Company’s 2022 Equity Incentive Plan (as amended) to (i) increase the number of shares authorized for issuance thereunder by 1,300,000 shares to 2,765,789 shares and (ii) increase the number of shares authorized for issuance thereunder pursuant to the exercise of ISOs to 2,765,789 shares. For Against Abstentions Broker Non-Votes 3,337,435 1,009,991 9,016 1,880,745 Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 104 Cover Page Interactive Data File, formatted in Inline Extensible Business Reporting Language (iXBRL). 2 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SCILEX HOLDING COMPANY By: /s/ Henry Ji, Ph.D. Name: Henry Ji, Ph.D. Date: June 24, 2026 Title: Chief Executive Officer & President 3